A deadlier strain of mpox has been confirmed in four African countries, sparking alarm among health officials worldwide. The Democratic Republic of Congo has reported over 14,000 cases and 511 deaths, with the virus spreading to Burundi, Kenya, Rwanda, and Uganda. The World Health Organization (WHO) is considering declaring a public health emergency of international concern.
Mpox, previously known as monkeypox, is a highly contagious viral disease that can be transmitted through close contact and contaminated materials. Symptoms include fever, rash, headache, and muscle pain. The disease has historically been prevalent in Central and West Africa but has recently spread to Europe and North America.
There are two genetic clades of mpox, with Clade Ib causing the current severe outbreak in the DRC. While it is more lethal, there is no evidence of increased transmissibility. The WHO and CDC are closely monitoring the situation and recommending heightened vigilance for travelers from affected regions.
Despite the rising cases in the DRC, the risk of global spread remains low. The CDC advises vaccination for high-risk individuals and those exposed to the virus. The WHO is expediting access to approved vaccines for lower-income countries and has initiated a regional response plan requiring $15 million in funding.
International cooperation is crucial in containing the outbreak, with WHO urging for support to prevent further escalation. Dr. Michael Ryan emphasized the importance of timely intervention and proper funding to effectively control the virus.
